ELISA 2 - ELISA 2

Description:

The goal of the trial was to evaluate treatment with dual antiplatelet therapy with aspirin and clopidogrel compared with triple antiplatelet therapy with aspirin, clopidogrel, and the glycoprotein (GP) IIb/IIIa inhibitor tirofiban among patients with non-ST elevation myocardial infarction (NSTEMI) undergoing angiography with or without revascularization.